Apimeds Pharmaceuticals US, Inc. (APUS)

CIK 1894525 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Apimeds Pharmaceuticals US, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 20268-K0001213900-26-099002
Aug 21, 20268-K0001213900-26-092680
Aug 14, 202610-Q0001213900-26-090120
Aug 6, 20268-K0001213900-26-086244
Jul 13, 20268-K0001213900-26-077591
May 26, 202610-Q0001213900-26-061013
May 15, 2026NT 10-Q0001213900-26-057713
May 7, 2026SCHEDULE 13D/A0001213900-26-053091
May 5, 20268-K0001213900-26-052036
May 4, 20268-K0001213900-26-051125
May 4, 202610-K0001213900-26-051139
Apr 22, 20268-K0001213900-26-046671
Apr 16, 20268-K0001213900-26-044657
Apr 9, 20268-K/A0001213900-26-042017
Apr 9, 20264250001213900-26-042030
Mar 31, 2026NT 10-K0001213900-26-037575
Mar 30, 2026SCHEDULE 13D/A0001213900-26-035996
Mar 26, 20268-K0001213900-26-034786
Mar 25, 20268-K0001213900-26-033832
Mar 20, 2026SCHEDULE 13D/A0001213900-26-032480
Mar 16, 20268-K0001213900-26-028332
Feb 27, 2026DEFM14C0001213900-26-020883
Feb 17, 20268-K/A0001213900-26-017323
Feb 17, 20264250001213900-26-017331
Feb 11, 2026SCHEDULE 13G0001493152-26-006136